APO Research
Talk to an analyst

APO RESEARCH · REPORT

Helicobacter Pylori Diagnostics

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Selected research

Market Outlook & Growth Opportunities

Global Helicobacter Pylori Diagnostics Market Outlook and Growth Opportunities 2026

1 January 2026197 pages

Choose your research edition.

Industry ResearchHelicobacter Pylori Diagnostics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Helicobacter Pylori Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Helicobacter Pylori Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Helicobacter Pylori Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Helicobacter Pylori Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. In the present report, we mainly studies the Helicobacter pylori diagnostic reagent or test box market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Helicobacter Pylori Diagnostics market by product and Application/end industries.

Global Helicobacter Pylori Diagnostics key players include Sekisui Diagnostics, Medline Industries, F. Hoffmann-La Roche, Meridian Bioscience, Bio-Rad Laboratories, etc. Global top five manufacturers hold a share about 85%. Europe is the largest market, with a share about 30%, followed by Asia-Pacific and North America, both with a share about 25 percent. In terms of product, Non-invasive Techniques is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospitals and Clinics, followed by Diagnostic Laboratories, etc.

This report provides an overview of the global Helicobacter Pylori Diagnostics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Helicobacter Pylori Diagnostics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Helicobacter Pylori Diagnostics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Helicobacter Pylori Diagnostics market.

Helicobacter Pylori Diagnostics Segment by Company

Sekisui Diagnostics

F. Hoffmann-La Roche

Medline Industries

Meridian Bioscience

Bio-Rad Laboratories

Thermo Fisher Scientific

Alpha Laboratories

EKF Diagnostics

Quidel

Halyard Health

Cardinal Health

Beckman Coulter

Agilent Technologies

Coris BioConcept

Helicobacter Pylori Diagnostics Segment by Type

Invasive Techniques

Non-invasive Techniques

Helicobacter Pylori Diagnostics Segment by Application

Hospitals and Clinics

Diagnostic Laboratories

Others

Helicobacter Pylori Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Helicobacter Pylori Diagnostics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Helicobacter Pylori Diagnostics key companies, revenue, market share, and recent developments.

3. To split the Helicobacter Pylori Diagnostics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Helicobacter Pylori Diagnostics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Helicobacter Pylori Diagnostics significant trends, drivers, influence factors in global and regions.

6. To analyze Helicobacter Pylori Diagnostics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Helicobacter Pylori Diagnostics industry.

Chapter 3: Detailed analysis of Helicobacter Pylori Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Helicobacter Pylori Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Helicobacter Pylori Diagnostics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Helicobacter Pylori Diagnostics Industry Trends Table 2. Helicobacter Pylori Diagnostics Industry Drivers Table 3. Helicobacter Pylori Diagnostics Industry Opportunities and Challenges Table 4. Helicobacter Pylori Diagnostics Industry Restraints Table 5. Global Helicobacter Pylori Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Helicobacter Pylori Diagnostics Revenue Share by Company (2021-2026) Table 7. Global Helicobacter Pylori Diagnostics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Helicobacter Pylori Diagnostics Key Company Manufacturing Base & Headquarters Table 9. Global Helicobacter Pylori Diagnostics Company, Product Type & Application Table 10. Global Helicobacter Pylori Diagnostics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Helicobacter Pylori Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Invasive Techniques Table 15. Significant Companies of Non-invasive Techniques Table 16. Global Helicobacter Pylori Diagnostics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Helicobacter Pylori Diagnostics Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Helicobacter Pylori Diagnostics Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2021-2026) Table 20. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals and Clinics Table 22. Significant Companies of Diagnostic Laboratories Table 23. Significant Companies of Others Table 24. Global Helicobacter Pylori Diagnostics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Helicobacter Pylori Diagnostics Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Helicobacter Pylori Diagnostics Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2021-2026) Table 28. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2027-2032) Table 29. Global Helicobacter Pylori Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Helicobacter Pylori Diagnostics Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Helicobacter Pylori Diagnostics Sales Value Share by Region (2021-2026) Table 32. Global Helicobacter Pylori Diagnostics Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Helicobacter Pylori Diagnostics Sales Value Share by Region (2027-2032) Table 34. Global Helicobacter Pylori Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Helicobacter Pylori Diagnostics Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Country (2021-2026) Table 37. Global Helicobacter Pylori Diagnostics Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Helicobacter Pylori Diagnostics Sales Value Market Share by Country (2027-2032) Table 39. Sekisui Diagnostics Company Information Table 40. Sekisui Diagnostics Business Overview Table 41. Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio Table 43. Sekisui Diagnostics Recent Development Table 44. F. Hoffmann-La Roche Company Information Table 45. F. Hoffmann-La Roche Business Overview Table 46. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio Table 48. F. Hoffmann-La Roche Recent Development Table 49. Medline Industries Company Information Table 50. Medline Industries Business Overview Table 51. Medline Industries Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Medline Industries Helicobacter Pylori Diagnostics Product Portfolio Table 53. Medline Industries Recent Development Table 54. Meridian Bioscience Company Information Table 55. Meridian Bioscience Business Overview Table 56. Meridian Bioscience Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio Table 58. Meridian Bioscience Recent Development Table 59. Bio-Rad Laboratories Company Information Table 60. Bio-Rad Laboratories Business Overview Table 61. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio Table 63. Bio-Rad Laboratories Recent Development Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. Alpha Laboratories Company Information Table 70. Alpha Laboratories Business Overview Table 71. Alpha Laboratories Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio Table 73. Alpha Laboratories Recent Development Table 74. EKF Diagnostics Company Information Table 75. EKF Diagnostics Business Overview Table 76. EKF Diagnostics Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio Table 78. EKF Diagnostics Recent Development Table 79. Quidel Company Information Table 80. Quidel Business Overview Table 81. Quidel Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Quidel Helicobacter Pylori Diagnostics Product Portfolio Table 83. Quidel Recent Development Table 84. Halyard Health Company Information Table 85. Halyard Health Business Overview Table 86. Halyard Health Helicobacter Pylori Diagnostics Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Halyard Health Helicobacter Pylori Diagnostics Product Portfolio Table 88. Halyard Health Recent Development Table 89. Cardinal Health Company Information Table 90. Cardinal Health Business Overview Table 91. Cardinal Health Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio Table 93. Cardinal Health Recent Development Table 94. Beckman Coulter Company Information Table 95. Beckman Coulter Business Overview Table 96. Beckman Coulter Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio Table 98. Beckman Coulter Recent Development Table 99. Agilent Technologies Company Information Table 100. Agilent Technologies Business Overview Table 101. Agilent Technologies Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio Table 103. Agilent Technologies Recent Development Table 104. Coris BioConcept Company Information Table 105. Coris BioConcept Business Overview Table 106. Coris BioConcept Helicobacter Pylori Diagnostics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio Table 108. Coris BioConcept Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Helicobacter Pylori Diagnostics Product Image Figure 2. Global Helicobacter Pylori Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Helicobacter Pylori Diagnostics Market Size (2021-2032) & (US$ Million) Figure 4. Global Helicobacter Pylori Diagnostics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Invasive Techniques Image Figure 8. Non-invasive Techniques Image Figure 9. Global Helicobacter Pylori Diagnostics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Helicobacter Pylori Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2021-2032) Figure 12. Hospitals and Clinics Image Figure 13. Diagnostic Laboratories Image Figure 14. Others Image Figure 15. Global Helicobacter Pylori Diagnostics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Helicobacter Pylori Diagnostics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2021-2032) Figure 18. Global Helicobacter Pylori Diagnostics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Helicobacter Pylori Diagnostics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Helicobacter Pylori Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 21. North America Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Helicobacter Pylori Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Helicobacter Pylori Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Helicobacter Pylori Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 27. South America Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Helicobacter Pylori Diagnostics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Invasive Techniques
  • Non-invasive Techniques
Applications
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others
Companies covered
  • Sekisui Diagnostics
  • F. Hoffmann-La Roche
  • Medline Industries
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Alpha Laboratories
  • EKF Diagnostics
  • Quidel
  • Halyard Health
  • Cardinal Health
  • Beckman Coulter
  • Agilent Technologies
  • Coris BioConcept

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Helicobacter Pylori Diagnostics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Helicobacter Pylori Diagnostics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Helicobacter Pylori Diagnostics Market Dynamics
  1. 2.1 Helicobacter Pylori Diagnostics Industry Trends
  2. 2.2 Helicobacter Pylori Diagnostics Industry Drivers
  3. 2.3 Helicobacter Pylori Diagnostics Industry Opportunities and Challenges
  4. 2.4 Helicobacter Pylori Diagnostics Industry Restraints
3 Helicobacter Pylori Diagnostics Market by Company
  1. 3.1 Global Helicobacter Pylori Diagnostics Company Revenue Ranking in 2025
  2. 3.2 Global Helicobacter Pylori Diagnostics Revenue by Company (2021-2026)
  3. 3.3 Global Helicobacter Pylori Diagnostics Company Ranking (2024-2026)
  4. 3.4 Global Helicobacter Pylori Diagnostics Company Manufacturing Base and Headquarters
  5. 3.5 Global Helicobacter Pylori Diagnostics Company Product Type and Application
  6. 3.6 Global Helicobacter Pylori Diagnostics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Helicobacter Pylori Diagnostics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Helicobacter Pylori Diagnostics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Helicobacter Pylori Diagnostics Market by Type
  1. 4.1 Helicobacter Pylori Diagnostics Type Introduction
  2. 4.1.1 Invasive Techniques
  3. 4.1.2 Non-invasive Techniques
  4. 4.2 Global Helicobacter Pylori Diagnostics Sales Value by Type
  5. 4.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Type (2021-2032)
  7. 4.2.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Type (2021-2032)
5 Helicobacter Pylori Diagnostics Market by Application
  1. 5.1 Helicobacter Pylori Diagnostics Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Diagnostic Laboratories
  4. 5.1.3 Others
  5. 5.2 Global Helicobacter Pylori Diagnostics Sales Value by Application
  6. 5.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Application (2021-2032)
  8. 5.2.3 Global Helicobacter Pylori Diagnostics Sales Value Share by Application (2021-2032)
6 Helicobacter Pylori Diagnostics Regional Value Analysis
  1. 6.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Helicobacter Pylori Diagnostics Sales Value (2021-2032)
  7. 6.3.2 North America Helicobacter Pylori Diagnostics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Helicobacter Pylori Diagnostics Sales Value (2021-2032)
  10. 6.4.2 Europe Helicobacter Pylori Diagnostics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Helicobacter Pylori Diagnostics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Helicobacter Pylori Diagnostics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Helicobacter Pylori Diagnostics Sales Value (2021-2032)
  16. 6.6.2 South America Helicobacter Pylori Diagnostics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Helicobacter Pylori Diagnostics Sales Value Share by Country, 2025 VS 2032
7 Helicobacter Pylori Diagnostics Country-level Value Analysis
  1. 7.1 Global Helicobacter Pylori Diagnostics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Helicobacter Pylori Diagnostics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Helicobacter Pylori Diagnostics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Helicobacter Pylori Diagnostics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Helicobacter Pylori Diagnostics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Helicobacter Pylori Diagnostics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Helicobacter Pylori Diagnostics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sekisui Diagnostics
  2. 8.1.1 Sekisui Diagnostics Company Information
  3. 8.1.2 Sekisui Diagnostics Business Overview
  4. 8.1.3 Sekisui Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sekisui Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
  6. 8.1.5 Sekisui Diagnostics Recent Developments
  7. 8.2 F. Hoffmann-La Roche
  8. 8.2.1 F. Hoffmann-La Roche Company Information
  9. 8.2.2 F. Hoffmann-La Roche Business Overview
  10. 8.2.3 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 F. Hoffmann-La Roche Helicobacter Pylori Diagnostics Product Portfolio
  12. 8.2.5 F. Hoffmann-La Roche Recent Developments
  13. 8.3 Medline Industries
  14. 8.3.1 Medline Industries Company Information
  15. 8.3.2 Medline Industries Business Overview
  16. 8.3.3 Medline Industries Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medline Industries Helicobacter Pylori Diagnostics Product Portfolio
  18. 8.3.5 Medline Industries Recent Developments
  19. 8.4 Meridian Bioscience
  20. 8.4.1 Meridian Bioscience Company Information
  21. 8.4.2 Meridian Bioscience Business Overview
  22. 8.4.3 Meridian Bioscience Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Meridian Bioscience Helicobacter Pylori Diagnostics Product Portfolio
  24. 8.4.5 Meridian Bioscience Recent Developments
  25. 8.5 Bio-Rad Laboratories
  26. 8.5.1 Bio-Rad Laboratories Company Information
  27. 8.5.2 Bio-Rad Laboratories Business Overview
  28. 8.5.3 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad Laboratories Helicobacter Pylori Diagnostics Product Portfolio
  30. 8.5.5 Bio-Rad Laboratories Recent Developments
  31. 8.6 Thermo Fisher Scientific
  32. 8.6.1 Thermo Fisher Scientific Company Information
  33. 8.6.2 Thermo Fisher Scientific Business Overview
  34. 8.6.3 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Thermo Fisher Scientific Helicobacter Pylori Diagnostics Product Portfolio
  36. 8.6.5 Thermo Fisher Scientific Recent Developments
  37. 8.7 Alpha Laboratories
  38. 8.7.1 Alpha Laboratories Company Information
  39. 8.7.2 Alpha Laboratories Business Overview
  40. 8.7.3 Alpha Laboratories Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alpha Laboratories Helicobacter Pylori Diagnostics Product Portfolio
  42. 8.7.5 Alpha Laboratories Recent Developments
  43. 8.8 EKF Diagnostics
  44. 8.8.1 EKF Diagnostics Company Information
  45. 8.8.2 EKF Diagnostics Business Overview
  46. 8.8.3 EKF Diagnostics Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 EKF Diagnostics Helicobacter Pylori Diagnostics Product Portfolio
  48. 8.8.5 EKF Diagnostics Recent Developments
  49. 8.9 Quidel
  50. 8.9.1 Quidel Company Information
  51. 8.9.2 Quidel Business Overview
  52. 8.9.3 Quidel Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Quidel Helicobacter Pylori Diagnostics Product Portfolio
  54. 8.9.5 Quidel Recent Developments
  55. 8.10 Halyard Health
  56. 8.10.1 Halyard Health Company Information
  57. 8.10.2 Halyard Health Business Overview
  58. 8.10.3 Halyard Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Halyard Health Helicobacter Pylori Diagnostics Product Portfolio
  60. 8.10.5 Halyard Health Recent Developments
  61. 8.11 Cardinal Health
  62. 8.11.1 Cardinal Health Company Information
  63. 8.11.2 Cardinal Health Business Overview
  64. 8.11.3 Cardinal Health Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cardinal Health Helicobacter Pylori Diagnostics Product Portfolio
  66. 8.11.5 Cardinal Health Recent Developments
  67. 8.12 Beckman Coulter
  68. 8.12.1 Beckman Coulter Company Information
  69. 8.12.2 Beckman Coulter Business Overview
  70. 8.12.3 Beckman Coulter Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beckman Coulter Helicobacter Pylori Diagnostics Product Portfolio
  72. 8.12.5 Beckman Coulter Recent Developments
  73. 8.13 Agilent Technologies
  74. 8.13.1 Agilent Technologies Company Information
  75. 8.13.2 Agilent Technologies Business Overview
  76. 8.13.3 Agilent Technologies Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Agilent Technologies Helicobacter Pylori Diagnostics Product Portfolio
  78. 8.13.5 Agilent Technologies Recent Developments
  79. 8.14 Coris BioConcept
  80. 8.14.1 Coris BioConcept Company Information
  81. 8.14.2 Coris BioConcept Business Overview
  82. 8.14.3 Coris BioConcept Helicobacter Pylori Diagnostics Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Coris BioConcept Helicobacter Pylori Diagnostics Product Portfolio
  84. 8.14.5 Coris BioConcept Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst